A systems approach towards an understanding, diagnosis and personalized treatment of autism spectrum disorders

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.9, 2011-09, pp. : 1235-1238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Melatonin in Autism Spectrum Disorders

Current Clinical Pharmacology, Vol. 9, Iss. 4, 2014-11 ,pp. : 326-334

Bentham Science Publishers

Access to resources Recommend Favorite

New directions in the treatment of autism spectrum disorders from animal model research

By Chadman Kathryn K Guariglia Sara R Yoo Jiyeon Helen

Expert Opinion on Drug Discovery, Vol. 7, Iss. 5, 2012-05 ,pp. : 407-416

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders

By Wink Logan K Plawecki Martin H Erickson Craig A Stigler Kimberly A McDougle Christopher J

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. : 481-494

Informa Healthcare

Access to resources Recommend Favorite

Neurobiological Basis and Pharmacologic Treatment of Social Impairment in Autism Spectrum Disorders

By Yui K. Koshiba M. Nakamura S.

Current Psychopharmacology, Vol. 1, Iss. 3, 2012-08 ,pp. : 233-246

Bentham Science Publishers

Access to resources Recommend Favorite

Neurobiological Basis and Pharmacologic Treatment of Social Impairment in Autism Spectrum Disorders

Current Psychopharmacology, Vol. 1, Iss. 3, 2012-01 ,pp. : 233-246

Bentham Science Publishers

Access to resources Recommend Favorite